Compounds > fluphenazine

fluphenazine and dantrolene

fluphenazine has been researched along with dantrolene in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brenner, R; Kahan, M; Lesser, MS; Nayak, D1
Adler, S; Coyle, J; Granato, JE; Karim, AH; Krumholz, A; Ringel, A; Stern, BJ1
Cape, G1
Baumgartner, R; Gönner, F; Merlo, MC; Schüpbach, D1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for fluphenazine and dantrolene

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for fluphenazine and dantrolene

ArticleYear
Dantrolene sodium as a possible prophylactic agent against N.M.S.
    The Hillside journal of clinical psychiatry, 1986, Volume: 8, Issue:1

    Topics: Adult; Dantrolene; Fluphenazine; Humans; Male; Neuroleptic Malignant Syndrome; Recurrence; Schizophrenia

1986
Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.
    Annals of neurology, 1983, Volume: 14, Issue:1

    Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Drug Therapy, Combination; Fluphenazine; Humans; Male; Schizophrenia

1983
Neuroleptic malignant syndrome--a cautionary tale and a surprising outcome.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 164, Issue:1

    Topics: Activities of Daily Living; Adaptation, Psychological; Adult; Antisocial Personality Disorder; Combined Modality Therapy; Critical Care; Dantrolene; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Follow-Up Studies; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Schizoid Personality Disorder; Sick Role; Social Environment; Substance Withdrawal Syndrome

1994
Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report.
    Psychopharmacology, 1999, Volume: 144, Issue:4

    Topics: Adult; Antipsychotic Agents; Clozapine; Dantrolene; Female; Fluphenazine; Humans; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Psychotic Disorders

1999
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012